dalteparin has been researched along with Metabolic Diseases in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selgas, R | 1 |
| Del Peso, G | 1 |
| Sánchez Villanueva, R | 1 |
| Aroeira, LS | 1 |
| Fernández Perpén, A | 1 |
| Ortiz, A | 1 |
| Ruiz Ortega, M | 1 |
| Sánchez-Tomero, JA | 1 |
| Martínez, J | 1 |
| Marrón, B | 1 |
| Bajo, MA | 1 |
1 other study available for dalteparin and Metabolic Diseases
| Article | Year |
|---|---|
[Theoretical bases for the proposal of a randomized, controlled, open label clinical trial to assess the efficacy of adding bemiparin to the icodextrin solution in patients on peritoneal dialysis with peritoneal transport disorders [FRIAT-BEM-2005-01]].
Topics: Glucans; Glucose; Hemodialysis Solutions; Heparin, Low-Molecular-Weight; Humans; Icodextrin; Metabol | 2008 |